Cargando…

Comorbid Depressive and Anxiety Symptoms in a Patient with Myasthenia Gravis

INTRODUCTION: Myasthenia gravis (MG) is a chronic illness most commonly found in women under 40 years. The most common psychiatric comorbidities found in MG include depressive and anxiety disorders. CLINICAL PRESENTATION: We describe a case of a 43-year-old African American female with MG who was br...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherukupally, Karthik R, Kodjo, Kodjovi, Ogunsakin, Oluwaseun, Olayinka, Olaniyi, Fouron, Patrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984743/
https://www.ncbi.nlm.nih.gov/pubmed/32089937
http://dx.doi.org/10.1155/2020/8967818
_version_ 1783491688328593408
author Cherukupally, Karthik R
Kodjo, Kodjovi
Ogunsakin, Oluwaseun
Olayinka, Olaniyi
Fouron, Patrice
author_facet Cherukupally, Karthik R
Kodjo, Kodjovi
Ogunsakin, Oluwaseun
Olayinka, Olaniyi
Fouron, Patrice
author_sort Cherukupally, Karthik R
collection PubMed
description INTRODUCTION: Myasthenia gravis (MG) is a chronic illness most commonly found in women under 40 years. The most common psychiatric comorbidities found in MG include depressive and anxiety disorders. CLINICAL PRESENTATION: We describe a case of a 43-year-old African American female with MG who was brought in for shortness of breath. History included MG diagnosed twelve years prior to the current presentation and a history of seven intubations. The patient was admitted to the ICU and intubated. She endorsed poor sleep, easy fatigability, and feeling hopeless in the context of psychosocial stressors—being single, homeless, and unemployed. The patient was started on Zoloft 50 mg per oral daily for depression and Atarax 50 mg per oral three times a day for anxiety. The patient responded well to the treatment and was discharged on day 10 after the resolution of her symptoms with appropriate aftercare in place. DISCUSSION: Depressive and anxiety symptoms usually develop as comorbidity during MG disease. Depressive and anxiety symptoms, besides motor symptoms, have a negative impact on the quality of life. Mental health must be a clinical focus during the treatment of somatic symptoms during MG.
format Online
Article
Text
id pubmed-6984743
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-69847432020-02-21 Comorbid Depressive and Anxiety Symptoms in a Patient with Myasthenia Gravis Cherukupally, Karthik R Kodjo, Kodjovi Ogunsakin, Oluwaseun Olayinka, Olaniyi Fouron, Patrice Case Rep Psychiatry Case Report INTRODUCTION: Myasthenia gravis (MG) is a chronic illness most commonly found in women under 40 years. The most common psychiatric comorbidities found in MG include depressive and anxiety disorders. CLINICAL PRESENTATION: We describe a case of a 43-year-old African American female with MG who was brought in for shortness of breath. History included MG diagnosed twelve years prior to the current presentation and a history of seven intubations. The patient was admitted to the ICU and intubated. She endorsed poor sleep, easy fatigability, and feeling hopeless in the context of psychosocial stressors—being single, homeless, and unemployed. The patient was started on Zoloft 50 mg per oral daily for depression and Atarax 50 mg per oral three times a day for anxiety. The patient responded well to the treatment and was discharged on day 10 after the resolution of her symptoms with appropriate aftercare in place. DISCUSSION: Depressive and anxiety symptoms usually develop as comorbidity during MG disease. Depressive and anxiety symptoms, besides motor symptoms, have a negative impact on the quality of life. Mental health must be a clinical focus during the treatment of somatic symptoms during MG. Hindawi 2020-01-08 /pmc/articles/PMC6984743/ /pubmed/32089937 http://dx.doi.org/10.1155/2020/8967818 Text en Copyright © 2020 Karthik R Cherukupally et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Cherukupally, Karthik R
Kodjo, Kodjovi
Ogunsakin, Oluwaseun
Olayinka, Olaniyi
Fouron, Patrice
Comorbid Depressive and Anxiety Symptoms in a Patient with Myasthenia Gravis
title Comorbid Depressive and Anxiety Symptoms in a Patient with Myasthenia Gravis
title_full Comorbid Depressive and Anxiety Symptoms in a Patient with Myasthenia Gravis
title_fullStr Comorbid Depressive and Anxiety Symptoms in a Patient with Myasthenia Gravis
title_full_unstemmed Comorbid Depressive and Anxiety Symptoms in a Patient with Myasthenia Gravis
title_short Comorbid Depressive and Anxiety Symptoms in a Patient with Myasthenia Gravis
title_sort comorbid depressive and anxiety symptoms in a patient with myasthenia gravis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984743/
https://www.ncbi.nlm.nih.gov/pubmed/32089937
http://dx.doi.org/10.1155/2020/8967818
work_keys_str_mv AT cherukupallykarthikr comorbiddepressiveandanxietysymptomsinapatientwithmyastheniagravis
AT kodjokodjovi comorbiddepressiveandanxietysymptomsinapatientwithmyastheniagravis
AT ogunsakinoluwaseun comorbiddepressiveandanxietysymptomsinapatientwithmyastheniagravis
AT olayinkaolaniyi comorbiddepressiveandanxietysymptomsinapatientwithmyastheniagravis
AT fouronpatrice comorbiddepressiveandanxietysymptomsinapatientwithmyastheniagravis